Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing

Sandra L. Ross(University of Cambridge), Tara Arvedson(PharmatrophiX (United States))
PLoS ONE
August 24, 2017
Cited by 111


Related Papers